<irb:Schedule xmlns:irb="http://irb.mit.edu/irbnamespace"><irb:ScheduleMasterData><irb:ScheduleId>767</irb:ScheduleId><irb:CommitteeId>Full Committee</irb:CommitteeId><irb:CommitteeName>Full Committee</irb:CommitteeName><irb:ScheduleStatusCode>1</irb:ScheduleStatusCode><irb:ScheduleStatusDesc>Scheduled</irb:ScheduleStatusDesc><irb:ScheduledDate>2013-12-17-07:00</irb:ScheduledDate><irb:ScheduledTime>14:00:00.000-07:00</irb:ScheduledTime><irb:Place>IRB1 - Drachman A326</irb:Place><irb:ProtocolSubDeadline>2013-12-17-07:00</irb:ProtocolSubDeadline><irb:StartTime>00:00:00.000-07:00</irb:StartTime><irb:EndTime>00:00:00.000-07:00</irb:EndTime><irb:MaxProtocols>40</irb:MaxProtocols></irb:ScheduleMasterData><irb:ProtocolSubmission><irb:ProtocolSummary><irb:ProtocolMasterData><irb:ProtocolNumber>1312167010</irb:ProtocolNumber><irb:SequenceNumber>0</irb:SequenceNumber><irb:ProtocolTypeCode>1</irb:ProtocolTypeCode><irb:ProtocolTypeDesc>Standard</irb:ProtocolTypeDesc><irb:ProtocolStatusCode>200</irb:ProtocolStatusCode><irb:ProtocolStatusDesc>Active - Open to Enrollment</irb:ProtocolStatusDesc><irb:ProtocolTitle>The Brain on Whole Body Hyperthermia: A Neuroimaging Study</irb:ProtocolTitle><irb:ApprovalDate>2013-12-17-07:00</irb:ApprovalDate><irb:ExpirationDate>2014-12-16-07:00</irb:ExpirationDate></irb:ProtocolMasterData><irb:Investigator><irb:Person><irb:PersonID>107155810210</irb:PersonID><irb:LastName>Raison</irb:LastName><irb:Salutation/><irb:Firstname>Charles</irb:Firstname><irb:Fullname>Charles L Raison</irb:Fullname><irb:Email>craison@email.arizona.edu</irb:Email><irb:Degree xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:OfficeLocation xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:OfficePhone>520-626-6336</irb:OfficePhone><irb:Department_Organization xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:DirectoryTitle xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:AddressLine1>Psychiatry</irb:AddressLine1><irb:AddressLine2>245002</irb:AddressLine2><irb:AddressLine3/><irb:City>TUCSON</irb:City><irb:Country>USA</irb:Country><irb:State>AZ</irb:State><irb:PostalCode>85724-5002</irb:PostalCode><irb:CountryCode>USA</irb:CountryCode><irb:FaxNumber/><irb:PagerNumber/><irb:MobilePhoneNumber/></irb:Person><irb:PI_flag>true</irb:PI_flag></irb:Investigator><irb:FundingSource><irb:TypeOfFundingSource>Sponsor (internal funding)</irb:TypeOfFundingSource><irb:FundingSourceName>40000</irb:FundingSourceName></irb:FundingSource></irb:ProtocolSummary><irb:SubmissionDetails><irb:ProtocolNumber>1312167010</irb:ProtocolNumber><irb:SubmissionNumber>1</irb:SubmissionNumber><irb:SubmissionTypeCode>100</irb:SubmissionTypeCode><irb:SubmissionTypeDesc>Initial Protocol Application for Approval</irb:SubmissionTypeDesc><irb:ProtocolReviewTypeCode>1</irb:ProtocolReviewTypeCode><irb:ProtocolReviewTypeDesc>Full</irb:ProtocolReviewTypeDesc><irb:SubmissionStatusCode>203</irb:SubmissionStatusCode><irb:SubmissionStatusDesc>Approved</irb:SubmissionStatusDesc><irb:SubmissionDate>2013-12-16-07:00</irb:SubmissionDate><irb:YesVote>0</irb:YesVote><irb:NoVote>0</irb:NoVote><irb:AbstainerCount>0</irb:AbstainerCount><irb:VotingComments xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:ProtocolReviewer><irb:Person><irb:PersonID>103963832260</irb:PersonID><irb:LastName>Breitborde</irb:LastName><irb:Salutation/><irb:Firstname>Nicholas</irb:Firstname><irb:Fullname>Nicholas Jk Breitborde</irb:Fullname><irb:Email>breitbor@email.arizona.edu</irb:Email><irb:Degree xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:OfficeLocation xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:OfficePhone>520-626-7534</irb:OfficePhone><irb:Department_Organization xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:DirectoryTitle xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:AddressLine1>Psychiatry</irb:AddressLine1><irb:AddressLine2>245145</irb:AddressLine2><irb:AddressLine3/><irb:City>TUCSON</irb:City><irb:Country>USA</irb:Country><irb:State>AZ</irb:State><irb:PostalCode>85724-5002</irb:PostalCode><irb:CountryCode>USA</irb:CountryCode><irb:FaxNumber/><irb:PagerNumber/><irb:MobilePhoneNumber/></irb:Person><irb:ReviewerTypeDesc>Primary</irb:ReviewerTypeDesc><irb:ReviewerTypeCode>1</irb:ReviewerTypeCode></irb:ProtocolReviewer><irb:ProtocolReviewer><irb:Person><irb:PersonID>108957885630</irb:PersonID><irb:LastName>Davis</irb:LastName><irb:Salutation/><irb:Firstname>Angela</irb:Firstname><irb:Fullname>Angela  Davis</irb:Fullname><irb:Email>angelad1@email.arizona.edu</irb:Email><irb:Degree xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:OfficeLocation xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:OfficePhone>520-621-3513</irb:OfficePhone><irb:Department_Organization xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:DirectoryTitle xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:AddressLine1>VP for Research Office</irb:AddressLine1><irb:AddressLine2/><irb:AddressLine3/><irb:City>TUCSON</irb:City><irb:Country>USA</irb:Country><irb:State>AZ</irb:State><irb:PostalCode>85721-0066</irb:PostalCode><irb:CountryCode>USA</irb:CountryCode><irb:FaxNumber/><irb:PagerNumber/><irb:MobilePhoneNumber/></irb:Person><irb:ReviewerTypeDesc>Secondary</irb:ReviewerTypeDesc><irb:ReviewerTypeCode>2</irb:ReviewerTypeCode></irb:ProtocolReviewer><irb:SubmissionChecklistInfo/><irb:ActionType><irb:ActionId>6</irb:ActionId><irb:ActionTypeCode>204</irb:ActionTypeCode><irb:ActionTypeDescription>Approved</irb:ActionTypeDescription><irb:ActionDate>2013-12-19-07:00</irb:ActionDate><irb:ActionComments xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/></irb:ActionType></irb:SubmissionDetails><irb:Minutes><irb:ScheduleId>766</irb:ScheduleId><irb:EntryNumber>7</irb:EntryNumber><irb:EntryTypeCode>3</irb:EntryTypeCode><irb:EntryTypeDesc>Protocol</irb:EntryTypeDesc><irb:EntrySortCode>3</irb:EntrySortCode><irb:ProtocolNumber>1312167010</irb:ProtocolNumber><irb:PrivateCommentFlag>false</irb:PrivateCommentFlag><irb:ProtocolContingencyCode>71</irb:ProtocolContingencyCode><irb:MinuteEntry>Criteria for Approval has been met (45 CFR 46.111): The criteria for approval listed in 45 CFR 46.111 have been met (or if previously met, have not changed) in that (1) Risks to subjects are minimized: (i) By using procedures which are consistent with sound research design and which do not unnecessarily expose subjects to risk, and (ii) whenever appropriate, by using procedures already being performed on the subjects for diagnostic or treatment purposes. (2) Risks to subjects are reasonable in relation to anticipated benefits, if any, to subjects, and the importance of the knowledge that may reasonably be expected to result. In evaluating risks and benefits, the IRB should consider only those risks and benefits that may result from the research (as distinguished from risks and benefits of therapies subjects would receive even if not participating in the research). The IRB should not consider possible long-range effects of applying knowledge gained in the research (for example, the possible effects of the research on public policy) as among those research risks that fall within the purview of its responsibility. (3) Selection of subjects is equitable. In making this assessment the IRB should take into account the purposes of the research and the setting in which the research will be conducted and should be particularly cognizant of the special problems of research involving vulnerable populations, such as children, prisoners, pregnant women, mentally disabled persons, or economically or educationally disadvantaged persons. (4) Informed consent will be sought from each prospective subject or the subject's legally authorized representative, in accordance with, and to the extent required by 46.116. (5) Informed consent will be appropriately documented, in accordance with, and to the extent required by 46.117. (6) When appropriate, the research plan makes adequate provision for monitoring the data collected to ensure the safety of subjects. (7) When appropriate, there are adequate provisions to protect the privacy of subjects and to maintain the confidentiality of data. (b) When some or all of the subjects are likely to be vulnerable to coercion or undue influence, such as children, prisoners, pregnant women, mentally disabled persons, or economically or educationally disadvantaged persons, additional safeguards have been included in the study to protect the rights and welfare of these subjects.</irb:MinuteEntry></irb:Minutes></irb:ProtocolSubmission><irb:ProtocolSubmission><irb:ProtocolSummary><irb:ProtocolMasterData><irb:ProtocolNumber>1312167790</irb:ProtocolNumber><irb:SequenceNumber>0</irb:SequenceNumber><irb:ProtocolTypeCode>1</irb:ProtocolTypeCode><irb:ProtocolTypeDesc>Standard</irb:ProtocolTypeDesc><irb:ProtocolStatusCode>102</irb:ProtocolStatusCode><irb:ProtocolStatusDesc>Specific Minor Revisions Required</irb:ProtocolStatusDesc><irb:ProtocolTitle>Acupuncture versus medication: A comparison of treatments for overactive bladder in an elderly female population</irb:ProtocolTitle><irb:ProtocolDescription>Drug-Oxybutynin</irb:ProtocolDescription></irb:ProtocolMasterData><irb:Investigator><irb:Person><irb:PersonID>105280839669</irb:PersonID><irb:LastName>Addis</irb:LastName><irb:Salutation/><irb:Firstname>Ilana</irb:Firstname><irb:Fullname>Ilana B Addis</irb:Fullname><irb:Email>iaddis@email.arizona.edu</irb:Email><irb:Degree xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:OfficeLocation xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:OfficePhone>520-626-6591</irb:OfficePhone><irb:Department_Organization xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:DirectoryTitle xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:AddressLine1>Obstetrics and Gynecology</irb:AddressLine1><irb:AddressLine2>245078</irb:AddressLine2><irb:AddressLine3/><irb:City>TUCSON</irb:City><irb:Country>USA</irb:Country><irb:State>AZ</irb:State><irb:PostalCode>85724-5078</irb:PostalCode><irb:CountryCode>USA</irb:CountryCode><irb:FaxNumber/><irb:PagerNumber/><irb:MobilePhoneNumber/></irb:Person><irb:PI_flag>true</irb:PI_flag></irb:Investigator><irb:FundingSource><irb:TypeOfFundingSource>Sponsor (external funding)</irb:TypeOfFundingSource><irb:FundingSourceName>National Institute on Aging</irb:FundingSourceName></irb:FundingSource></irb:ProtocolSummary><irb:SubmissionDetails><irb:ProtocolNumber>1312167790</irb:ProtocolNumber><irb:SubmissionNumber>1</irb:SubmissionNumber><irb:SubmissionTypeCode>100</irb:SubmissionTypeCode><irb:SubmissionTypeDesc>Initial Protocol Application for Approval</irb:SubmissionTypeDesc><irb:ProtocolReviewTypeCode>1</irb:ProtocolReviewTypeCode><irb:ProtocolReviewTypeDesc>Full</irb:ProtocolReviewTypeDesc><irb:SubmissionStatusCode>202</irb:SubmissionStatusCode><irb:SubmissionStatusDesc>Specific Minor Revisions Requested</irb:SubmissionStatusDesc><irb:SubmissionDate>2013-12-16-07:00</irb:SubmissionDate><irb:YesVote>0</irb:YesVote><irb:NoVote>0</irb:NoVote><irb:AbstainerCount>0</irb:AbstainerCount><irb:VotingComments xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:ProtocolReviewer><irb:Person><irb:PersonID>111164726552</irb:PersonID><irb:LastName>Camamo</irb:LastName><irb:Salutation/><irb:Firstname>James</irb:Firstname><irb:Fullname>James Michael Camamo</irb:Fullname><irb:Email/><irb:Degree xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:OfficeLocation xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:OfficePhone>520-694-2283</irb:OfficePhone><irb:Department_Organization xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:DirectoryTitle xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:AddressLine1>Pharmacy Practice and Science</irb:AddressLine1><irb:AddressLine2/><irb:AddressLine3/><irb:City>TUCSON</irb:City><irb:Country>USA</irb:Country><irb:State>AZ</irb:State><irb:PostalCode>85721-0207</irb:PostalCode><irb:CountryCode>USA</irb:CountryCode><irb:FaxNumber/><irb:PagerNumber/><irb:MobilePhoneNumber/></irb:Person><irb:ReviewerTypeDesc>Secondary</irb:ReviewerTypeDesc><irb:ReviewerTypeCode>2</irb:ReviewerTypeCode></irb:ProtocolReviewer><irb:ProtocolReviewer><irb:Person><irb:PersonID>118063720242</irb:PersonID><irb:LastName>Hill</irb:LastName><irb:Salutation/><irb:Firstname>Meghan</irb:Firstname><irb:Fullname>Meghan G Hill</irb:Fullname><irb:Email>meghanhill@email.arizona.edu</irb:Email><irb:Degree xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:OfficeLocation xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:OfficePhone>520-626-6636</irb:OfficePhone><irb:Department_Organization xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:DirectoryTitle xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:AddressLine1>Obstetrics and Gynecology</irb:AddressLine1><irb:AddressLine2>245078</irb:AddressLine2><irb:AddressLine3/><irb:City>TUCSON</irb:City><irb:Country>USA</irb:Country><irb:State>AZ</irb:State><irb:PostalCode>85724-5078</irb:PostalCode><irb:CountryCode>USA</irb:CountryCode><irb:FaxNumber/><irb:PagerNumber/><irb:MobilePhoneNumber/></irb:Person><irb:ReviewerTypeDesc>Primary</irb:ReviewerTypeDesc><irb:ReviewerTypeCode>1</irb:ReviewerTypeCode></irb:ProtocolReviewer><irb:SubmissionChecklistInfo/><irb:ActionType><irb:ActionId>2</irb:ActionId><irb:ActionTypeCode>101</irb:ActionTypeCode><irb:ActionTypeDescription>Submitted to IRB</irb:ActionTypeDescription><irb:ActionDate>2013-12-16-07:00</irb:ActionDate><irb:ActionComments>Submitted to IRB</irb:ActionComments></irb:ActionType></irb:SubmissionDetails><irb:Minutes><irb:ScheduleId>766</irb:ScheduleId><irb:EntryNumber>0</irb:EntryNumber><irb:EntryTypeCode>3</irb:EntryTypeCode><irb:EntryTypeDesc>Protocol</irb:EntryTypeDesc><irb:EntrySortCode>3</irb:EntrySortCode><irb:ProtocolNumber>1312167790</irb:ProtocolNumber><irb:PrivateCommentFlag>false</irb:PrivateCommentFlag><irb:ProtocolContingencyCode>48</irb:ProtocolContingencyCode><irb:MinuteEntry>Please respond to the IRB Committee no later than Friday, December 6th.  If materials are not received by this date, the project will be withdrawn.  The PI must include the text of each comment followed by the response.  The version date of all revised documents must be updated to match the date of the Modifications and all revisions tracked or highlighted in gray.</irb:MinuteEntry></irb:Minutes></irb:ProtocolSubmission><irb:ProtocolSubmission><irb:ProtocolSummary><irb:ProtocolMasterData><irb:ProtocolNumber>1312166144</irb:ProtocolNumber><irb:SequenceNumber>0</irb:SequenceNumber><irb:ProtocolTypeCode>1</irb:ProtocolTypeCode><irb:ProtocolTypeDesc>Standard</irb:ProtocolTypeDesc><irb:ProtocolStatusCode>200</irb:ProtocolStatusCode><irb:ProtocolStatusDesc>Active - Open to Enrollment</irb:ProtocolStatusDesc><irb:ProtocolTitle>GRADS ALPHA-1 ANTITRYPSIN DEFICIENCY</irb:ProtocolTitle><irb:ApprovalDate>2013-12-17-07:00</irb:ApprovalDate><irb:ExpirationDate>2014-12-16-07:00</irb:ExpirationDate></irb:ProtocolMasterData><irb:Investigator><irb:Person><irb:PersonID>116670560447</irb:PersonID><irb:LastName>Garcia</irb:LastName><irb:Salutation/><irb:Firstname>Joe</irb:Firstname><irb:Fullname>Joe GN Garcia</irb:Fullname><irb:Email>skipgarcia@email.arizona.edu</irb:Email><irb:Degree xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:OfficeLocation xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:OfficePhone>520-626-1197</irb:OfficePhone><irb:Department_Organization xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:DirectoryTitle xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:AddressLine1>Senior VP Health Sciences</irb:AddressLine1><irb:AddressLine2>PO Box 210202</irb:AddressLine2><irb:AddressLine3/><irb:City>TUCSON</irb:City><irb:Country>USA</irb:Country><irb:State>AZ</irb:State><irb:PostalCode>85724-5019</irb:PostalCode><irb:CountryCode>USA</irb:CountryCode><irb:FaxNumber/><irb:PagerNumber/><irb:MobilePhoneNumber/></irb:Person><irb:PI_flag>true</irb:PI_flag></irb:Investigator><irb:FundingSource><irb:TypeOfFundingSource>Sponsor (external funding)</irb:TypeOfFundingSource><irb:FundingSourceName>National Heart, Lung, and Blood Institute</irb:FundingSourceName></irb:FundingSource></irb:ProtocolSummary><irb:SubmissionDetails><irb:ProtocolNumber>1312166144</irb:ProtocolNumber><irb:SubmissionNumber>1</irb:SubmissionNumber><irb:SubmissionTypeCode>100</irb:SubmissionTypeCode><irb:SubmissionTypeDesc>Initial Protocol Application for Approval</irb:SubmissionTypeDesc><irb:ProtocolReviewTypeCode>1</irb:ProtocolReviewTypeCode><irb:ProtocolReviewTypeDesc>Full</irb:ProtocolReviewTypeDesc><irb:SubmissionStatusCode>203</irb:SubmissionStatusCode><irb:SubmissionStatusDesc>Approved</irb:SubmissionStatusDesc><irb:SubmissionDate>2013-12-16-07:00</irb:SubmissionDate><irb:YesVote>0</irb:YesVote><irb:NoVote>0</irb:NoVote><irb:AbstainerCount>0</irb:AbstainerCount><irb:VotingComments xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:ProtocolReviewer><irb:Person><irb:PersonID>115605455407</irb:PersonID><irb:LastName>Goodwin</irb:LastName><irb:Salutation/><irb:Firstname>James</irb:Firstname><irb:Fullname>James L Goodwin</irb:Fullname><irb:Email>jamieg@arc.arizona.edu</irb:Email><irb:Degree xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:OfficeLocation xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:OfficePhone>520-626-5001</irb:OfficePhone><irb:Department_Organization xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:DirectoryTitle xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:AddressLine1>Arizona Respiratory Center</irb:AddressLine1><irb:AddressLine2>245030</irb:AddressLine2><irb:AddressLine3/><irb:City>TUCSON</irb:City><irb:Country>USA</irb:Country><irb:State>AZ</irb:State><irb:PostalCode>85724-5030</irb:PostalCode><irb:CountryCode>USA</irb:CountryCode><irb:FaxNumber/><irb:PagerNumber/><irb:MobilePhoneNumber/></irb:Person><irb:ReviewerTypeDesc>Primary</irb:ReviewerTypeDesc><irb:ReviewerTypeCode>1</irb:ReviewerTypeCode></irb:ProtocolReviewer><irb:ProtocolReviewer><irb:Person><irb:PersonID>112890550936</irb:PersonID><irb:LastName>Molina de Rodriguez</irb:LastName><irb:Salutation/><irb:Firstname>Osmara</irb:Firstname><irb:Fullname>Osmara Y Molina de Rodriguez</irb:Fullname><irb:Email>omolina@email.arizona.edu</irb:Email><irb:Degree xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:OfficeLocation xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:OfficePhone>520-626-3910</irb:OfficePhone><irb:Department_Organization xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:DirectoryTitle xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:AddressLine1>Arizona Respiratory Center</irb:AddressLine1><irb:AddressLine2>245030</irb:AddressLine2><irb:AddressLine3/><irb:City>TUCSON</irb:City><irb:Country>USA</irb:Country><irb:State>AZ</irb:State><irb:PostalCode>85724-5030</irb:PostalCode><irb:CountryCode>USA</irb:CountryCode><irb:FaxNumber/><irb:PagerNumber/><irb:MobilePhoneNumber/></irb:Person><irb:ReviewerTypeDesc>Secondary</irb:ReviewerTypeDesc><irb:ReviewerTypeCode>2</irb:ReviewerTypeCode></irb:ProtocolReviewer><irb:SubmissionChecklistInfo/><irb:ActionType><irb:ActionId>2</irb:ActionId><irb:ActionTypeCode>101</irb:ActionTypeCode><irb:ActionTypeDescription>Submitted to IRB</irb:ActionTypeDescription><irb:ActionDate>2013-12-16-07:00</irb:ActionDate><irb:ActionComments>Submitted to IRB</irb:ActionComments></irb:ActionType></irb:SubmissionDetails><irb:Minutes><irb:ScheduleId>766</irb:ScheduleId><irb:EntryNumber>8</irb:EntryNumber><irb:EntryTypeCode>3</irb:EntryTypeCode><irb:EntryTypeDesc>Protocol</irb:EntryTypeDesc><irb:EntrySortCode>3</irb:EntrySortCode><irb:ProtocolNumber>1312166144</irb:ProtocolNumber><irb:PrivateCommentFlag>false</irb:PrivateCommentFlag><irb:ProtocolContingencyCode>71</irb:ProtocolContingencyCode><irb:MinuteEntry>Criteria for Approval has been met (45 CFR 46.111): The criteria for approval listed in 45 CFR 46.111 have been met (or if previously met, have not changed) in that (1) Risks to subjects are minimized: (i) By using procedures which are consistent with sound research design and which do not unnecessarily expose subjects to risk, and (ii) whenever appropriate, by using procedures already being performed on the subjects for diagnostic or treatment purposes. (2) Risks to subjects are reasonable in relation to anticipated benefits, if any, to subjects, and the importance of the knowledge that may reasonably be expected to result. In evaluating risks and benefits, the IRB should consider only those risks and benefits that may result from the research (as distinguished from risks and benefits of therapies subjects would receive even if not participating in the research). The IRB should not consider possible long-range effects of applying knowledge gained in the research (for example, the possible effects of the research on public policy) as among those research risks that fall within the purview of its responsibility. (3) Selection of subjects is equitable. In making this assessment the IRB should take into account the purposes of the research and the setting in which the research will be conducted and should be particularly cognizant of the special problems of research involving vulnerable populations, such as children, prisoners, pregnant women, mentally disabled persons, or economically or educationally disadvantaged persons. (4) Informed consent will be sought from each prospective subject or the subject's legally authorized representative, in accordance with, and to the extent required by 46.116. (5) Informed consent will be appropriately documented, in accordance with, and to the extent required by 46.117. (6) When appropriate, the research plan makes adequate provision for monitoring the data collected to ensure the safety of subjects. (7) When appropriate, there are adequate provisions to protect the privacy of subjects and to maintain the confidentiality of data. (b) When some or all of the subjects are likely to be vulnerable to coercion or undue influence, such as children, prisoners, pregnant women, mentally disabled persons, or economically or educationally disadvantaged persons, additional safeguards have been included in the study to protect the rights and welfare of these subjects.</irb:MinuteEntry></irb:Minutes><irb:Minutes><irb:ScheduleId>766</irb:ScheduleId><irb:EntryNumber>9</irb:EntryNumber><irb:EntryTypeCode>3</irb:EntryTypeCode><irb:EntryTypeDesc>Protocol</irb:EntryTypeDesc><irb:EntrySortCode>3</irb:EntrySortCode><irb:ProtocolNumber>1312166144</irb:ProtocolNumber><irb:PrivateCommentFlag>false</irb:PrivateCommentFlag><irb:ProtocolContingencyCode>124</irb:ProtocolContingencyCode><irb:MinuteEntry>Partial Waiver Waiver of PHI Authorization (45 CFR 164.512(i)(2)(ii)): As documented in the file, the use or disclosure of protected health information involves no more than minimal risk to the individuals ; the research could not practicably be conducted without the alteration or waiver ;the research could not practicably be conducted without access to and use of the protected health information ; there is an adequate plan to protect the identifiers from improper use and disclosure ; there is an adequate plan to destroy the identifiers at the earliest opportunity consistent with conduct of the research, unless there is a health or research justification for retaining the identifiers, or such retention is otherwise required by law ; and there are adequate written assurances that the protected health information will not be reused or disclosed to any other person or entity, except as required by law, for authorized oversight of the research project, or for other research for which the use or disclosure of protected health information would be permitted by this subpart.</irb:MinuteEntry></irb:Minutes></irb:ProtocolSubmission><irb:ProtocolSubmission><irb:ProtocolSummary><irb:ProtocolMasterData><irb:ProtocolNumber>1200000988R002</irb:ProtocolNumber><irb:SequenceNumber>0</irb:SequenceNumber><irb:ProtocolTypeCode>1</irb:ProtocolTypeCode><irb:ProtocolTypeDesc>Standard</irb:ProtocolTypeDesc><irb:ProtocolStatusCode>401</irb:ProtocolStatusCode><irb:ProtocolStatusDesc>Renewal Incorporated into Protocol</irb:ProtocolStatusDesc><irb:ProtocolTitle>S1107 Parallel (Randomized) Phase II Evaluation of ARQ 197 and ARQ 197 in Combination with Erlotinib in Papillary Renal Cell Carcinoma(AZ017; AZ110)</irb:ProtocolTitle><irb:ProtocolDescription>ARQ 197, Erlotinib</irb:ProtocolDescription><irb:ApprovalDate>2013-01-15-07:00</irb:ApprovalDate><irb:ExpirationDate>2015-01-14-07:00</irb:ExpirationDate></irb:ProtocolMasterData><irb:Investigator><irb:Person><irb:PersonID>116286252712</irb:PersonID><irb:LastName>Singh</irb:LastName><irb:Salutation/><irb:Firstname>Parminder</irb:Firstname><irb:Fullname>Parminder  Singh</irb:Fullname><irb:Email>parmindersingh@email.arizona.edu</irb:Email><irb:Degree xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:OfficeLocation xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:OfficePhone>520-626-2218</irb:OfficePhone><irb:Department_Organization xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:DirectoryTitle xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:AddressLine1>Medicine</irb:AddressLine1><irb:AddressLine2>245024</irb:AddressLine2><irb:AddressLine3/><irb:City>TUCSON</irb:City><irb:Country>USA</irb:Country><irb:State>AZ</irb:State><irb:PostalCode>85724-5099</irb:PostalCode><irb:CountryCode>USA</irb:CountryCode><irb:FaxNumber/><irb:PagerNumber/><irb:MobilePhoneNumber/></irb:Person><irb:PI_flag>true</irb:PI_flag></irb:Investigator><irb:FundingSource><irb:TypeOfFundingSource>Sponsor (external funding)</irb:TypeOfFundingSource><irb:FundingSourceName>SWOG</irb:FundingSourceName></irb:FundingSource></irb:ProtocolSummary><irb:SubmissionDetails><irb:ProtocolNumber>1200000988R002</irb:ProtocolNumber><irb:SubmissionNumber>8</irb:SubmissionNumber><irb:SubmissionTypeCode>115</irb:SubmissionTypeCode><irb:SubmissionTypeDesc>Continuing Review/Continuation with Amendment</irb:SubmissionTypeDesc><irb:ProtocolReviewTypeCode>1</irb:ProtocolReviewTypeCode><irb:ProtocolReviewTypeDesc>Full</irb:ProtocolReviewTypeDesc><irb:SubmissionStatusCode>203</irb:SubmissionStatusCode><irb:SubmissionStatusDesc>Approved</irb:SubmissionStatusDesc><irb:SubmissionDate>2013-12-17-07:00</irb:SubmissionDate><irb:YesVote>0</irb:YesVote><irb:NoVote>0</irb:NoVote><irb:AbstainerCount>0</irb:AbstainerCount><irb:VotingComments xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:ProtocolReviewer><irb:Person><irb:PersonID>105554805524</irb:PersonID><irb:LastName>Harris</irb:LastName><irb:Salutation/><irb:Firstname>Jules</irb:Firstname><irb:Fullname>Jules E Harris</irb:Fullname><irb:Email>jjharris36@email.arizona.edu</irb:Email><irb:Degree xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:OfficeLocation xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:OfficePhone>520-626-6276</irb:OfficePhone><irb:Department_Organization xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:DirectoryTitle xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:AddressLine1>Medicine</irb:AddressLine1><irb:AddressLine2/><irb:AddressLine3/><irb:City>TUCSON</irb:City><irb:Country>USA</irb:Country><irb:State>AZ</irb:State><irb:PostalCode>85724-5099</irb:PostalCode><irb:CountryCode>USA</irb:CountryCode><irb:FaxNumber/><irb:PagerNumber/><irb:MobilePhoneNumber/></irb:Person><irb:ReviewerTypeDesc>Primary</irb:ReviewerTypeDesc><irb:ReviewerTypeCode>1</irb:ReviewerTypeCode></irb:ProtocolReviewer><irb:ProtocolReviewer><irb:Person><irb:PersonID>115545259718</irb:PersonID><irb:LastName>Moore</irb:LastName><irb:Salutation/><irb:Firstname>Ida</irb:Firstname><irb:Fullname>Ida M Moore</irb:Fullname><irb:Email>imoore@email.arizona.edu</irb:Email><irb:Degree xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:OfficeLocation xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:OfficePhone>520-626-6205</irb:OfficePhone><irb:Department_Organization xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:DirectoryTitle xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:AddressLine1>College of Nursing</irb:AddressLine1><irb:AddressLine2>PO Box 210203</irb:AddressLine2><irb:AddressLine3/><irb:City>Tucson</irb:City><irb:Country>USA</irb:Country><irb:State>AZ</irb:State><irb:PostalCode>85721</irb:PostalCode><irb:CountryCode>USA</irb:CountryCode><irb:FaxNumber/><irb:PagerNumber/><irb:MobilePhoneNumber/></irb:Person><irb:ReviewerTypeDesc>Secondary</irb:ReviewerTypeDesc><irb:ReviewerTypeCode>2</irb:ReviewerTypeCode></irb:ProtocolReviewer><irb:SubmissionChecklistInfo/><irb:ActionType><irb:ActionId>3</irb:ActionId><irb:ActionTypeCode>200</irb:ActionTypeCode><irb:ActionTypeDescription>Assigned to Agenda</irb:ActionTypeDescription><irb:ActionDate>2013-12-17-07:00</irb:ActionDate><irb:ActionComments xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/></irb:ActionType></irb:SubmissionDetails><irb:Minutes><irb:ScheduleId>766</irb:ScheduleId><irb:EntryNumber>1</irb:EntryNumber><irb:EntryTypeCode>3</irb:EntryTypeCode><irb:EntryTypeDesc>Protocol</irb:EntryTypeDesc><irb:EntrySortCode>3</irb:EntrySortCode><irb:ProtocolNumber>1200000988R002</irb:ProtocolNumber><irb:PrivateCommentFlag>false</irb:PrivateCommentFlag><irb:ProtocolContingencyCode>71</irb:ProtocolContingencyCode><irb:MinuteEntry>Criteria for Approval has been met (45 CFR 46.111): The criteria for approval listed in 45 CFR 46.111 have been met (or if previously met, have not changed) in that (1) Risks to subjects are minimized: (i) By using procedures which are consistent with sound research design and which do not unnecessarily expose subjects to risk, and (ii) whenever appropriate, by using procedures already being performed on the subjects for diagnostic or treatment purposes. (2) Risks to subjects are reasonable in relation to anticipated benefits, if any, to subjects, and the importance of the knowledge that may reasonably be expected to result. In evaluating risks and benefits, the IRB should consider only those risks and benefits that may result from the research (as distinguished from risks and benefits of therapies subjects would receive even if not participating in the research). The IRB should not consider possible long-range effects of applying knowledge gained in the research (for example, the possible effects of the research on public policy) as among those research risks that fall within the purview of its responsibility. (3) Selection of subjects is equitable. In making this assessment the IRB should take into account the purposes of the research and the setting in which the research will be conducted and should be particularly cognizant of the special problems of research involving vulnerable populations, such as children, prisoners, pregnant women, mentally disabled persons, or economically or educationally disadvantaged persons. (4) Informed consent will be sought from each prospective subject or the subject's legally authorized representative, in accordance with, and to the extent required by 46.116. (5) Informed consent will be appropriately documented, in accordance with, and to the extent required by 46.117. (6) When appropriate, the research plan makes adequate provision for monitoring the data collected to ensure the safety of subjects. (7) When appropriate, there are adequate provisions to protect the privacy of subjects and to maintain the confidentiality of data. (b) When some or all of the subjects are likely to be vulnerable to coercion or undue influence, such as children, prisoners, pregnant women, mentally disabled persons, or economically or educationally disadvantaged persons, additional safeguards have been included in the study to protect the rights and welfare of these subjects.</irb:MinuteEntry></irb:Minutes></irb:ProtocolSubmission><irb:ProtocolSubmission><irb:ProtocolSummary><irb:ProtocolMasterData><irb:ProtocolNumber>1200000988</irb:ProtocolNumber><irb:SequenceNumber>7</irb:SequenceNumber><irb:ProtocolTypeCode>1</irb:ProtocolTypeCode><irb:ProtocolTypeDesc>Standard</irb:ProtocolTypeDesc><irb:ProtocolStatusCode>200</irb:ProtocolStatusCode><irb:ProtocolStatusDesc>Active - Open to Enrollment</irb:ProtocolStatusDesc><irb:ProtocolTitle>S1107 Parallel (Randomized) Phase II Evaluation of ARQ 197 and ARQ 197 in Combination with Erlotinib in Papillary Renal Cell Carcinoma(AZ017; AZ110)</irb:ProtocolTitle><irb:ProtocolDescription>ARQ 197, Erlotinib</irb:ProtocolDescription><irb:ApprovalDate>2013-01-15-07:00</irb:ApprovalDate><irb:ExpirationDate>2015-01-14-07:00</irb:ExpirationDate></irb:ProtocolMasterData><irb:Investigator><irb:Person><irb:PersonID>116286252712</irb:PersonID><irb:LastName>Singh</irb:LastName><irb:Salutation/><irb:Firstname>Parminder</irb:Firstname><irb:Fullname>Parminder  Singh</irb:Fullname><irb:Email>parmindersingh@email.arizona.edu</irb:Email><irb:Degree xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:OfficeLocation xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:OfficePhone>520-626-2218</irb:OfficePhone><irb:Department_Organization xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:DirectoryTitle xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:AddressLine1>Medicine</irb:AddressLine1><irb:AddressLine2>245024</irb:AddressLine2><irb:AddressLine3/><irb:City>TUCSON</irb:City><irb:Country>USA</irb:Country><irb:State>AZ</irb:State><irb:PostalCode>85724-5099</irb:PostalCode><irb:CountryCode>USA</irb:CountryCode><irb:FaxNumber/><irb:PagerNumber/><irb:MobilePhoneNumber/></irb:Person><irb:PI_flag>true</irb:PI_flag></irb:Investigator><irb:FundingSource><irb:TypeOfFundingSource>Sponsor (external funding)</irb:TypeOfFundingSource><irb:FundingSourceName>SWOG</irb:FundingSourceName></irb:FundingSource></irb:ProtocolSummary><irb:SubmissionDetails><irb:ProtocolNumber>1200000988</irb:ProtocolNumber><irb:SubmissionNumber>8</irb:SubmissionNumber><irb:SubmissionTypeCode>115</irb:SubmissionTypeCode><irb:SubmissionTypeDesc>Continuing Review/Continuation with Amendment</irb:SubmissionTypeDesc><irb:ProtocolReviewTypeCode>1</irb:ProtocolReviewTypeCode><irb:ProtocolReviewTypeDesc>Full</irb:ProtocolReviewTypeDesc><irb:SubmissionStatusCode>203</irb:SubmissionStatusCode><irb:SubmissionStatusDesc>Approved</irb:SubmissionStatusDesc><irb:SubmissionDate>2013-12-17-07:00</irb:SubmissionDate><irb:YesVote>0</irb:YesVote><irb:NoVote>0</irb:NoVote><irb:AbstainerCount>0</irb:AbstainerCount><irb:VotingComments xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:SubmissionChecklistInfo/><irb:ActionType><irb:ActionId>5</irb:ActionId><irb:ActionTypeCode>308</irb:ActionTypeCode><irb:ActionTypeDescription>Record Committee Decision</irb:ActionTypeDescription><irb:ActionDate>2013-12-17-07:00</irb:ActionDate><irb:ActionComments>Renewal-002: </irb:ActionComments></irb:ActionType></irb:SubmissionDetails></irb:ProtocolSubmission><irb:ProtocolSubmission><irb:ProtocolSummary><irb:ProtocolMasterData><irb:ProtocolNumber>1312166321</irb:ProtocolNumber><irb:SequenceNumber>0</irb:SequenceNumber><irb:ProtocolTypeCode>1</irb:ProtocolTypeCode><irb:ProtocolTypeDesc>Standard</irb:ProtocolTypeDesc><irb:ProtocolStatusCode>200</irb:ProtocolStatusCode><irb:ProtocolStatusDesc>Active - Open to Enrollment</irb:ProtocolStatusDesc><irb:ProtocolTitle>MR WITNESS:  A Phase IIa Safety Study of Intravenous Thrombolysis with Alteplase in MRI-Selected Patients</irb:ProtocolTitle><irb:ApprovalDate>2013-12-17-07:00</irb:ApprovalDate><irb:ExpirationDate>2014-12-16-07:00</irb:ExpirationDate></irb:ProtocolMasterData><irb:Investigator><irb:Person><irb:PersonID>103223082275</irb:PersonID><irb:LastName>Drake</irb:LastName><irb:Salutation/><irb:Firstname>Kendra</irb:Firstname><irb:Fullname>Kendra W Drake</irb:Fullname><irb:Email>kdrake@email.arizona.edu</irb:Email><irb:Degree xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:OfficeLocation xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:OfficePhone>520-626-2006</irb:OfficePhone><irb:Department_Organization xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:DirectoryTitle xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:AddressLine1>Neurology</irb:AddressLine1><irb:AddressLine2>245023</irb:AddressLine2><irb:AddressLine3/><irb:City>TUCSON</irb:City><irb:Country>USA</irb:Country><irb:State>AZ</irb:State><irb:PostalCode>85724-5023</irb:PostalCode><irb:CountryCode>USA</irb:CountryCode><irb:FaxNumber/><irb:PagerNumber/><irb:MobilePhoneNumber/></irb:Person><irb:PI_flag>true</irb:PI_flag></irb:Investigator><irb:FundingSource><irb:TypeOfFundingSource>Sponsor (external funding)</irb:TypeOfFundingSource><irb:FundingSourceName>National Institute of Neurological Disorders and Stroke</irb:FundingSourceName></irb:FundingSource></irb:ProtocolSummary><irb:SubmissionDetails><irb:ProtocolNumber>1312166321</irb:ProtocolNumber><irb:SubmissionNumber>1</irb:SubmissionNumber><irb:SubmissionTypeCode>100</irb:SubmissionTypeCode><irb:SubmissionTypeDesc>Initial Protocol Application for Approval</irb:SubmissionTypeDesc><irb:ProtocolReviewTypeCode>1</irb:ProtocolReviewTypeCode><irb:ProtocolReviewTypeDesc>Full</irb:ProtocolReviewTypeDesc><irb:SubmissionStatusCode>203</irb:SubmissionStatusCode><irb:SubmissionStatusDesc>Approved</irb:SubmissionStatusDesc><irb:SubmissionDate>2013-12-16-07:00</irb:SubmissionDate><irb:YesVote>0</irb:YesVote><irb:NoVote>0</irb:NoVote><irb:AbstainerCount>0</irb:AbstainerCount><irb:VotingComments xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:ProtocolReviewer><irb:Person><irb:PersonID>113934908819</irb:PersonID><irb:LastName>Malkin</irb:LastName><irb:Salutation/><irb:Firstname>Martin</irb:Firstname><irb:Fullname>Martin  Malkin</irb:Fullname><irb:Email/><irb:Degree xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:OfficeLocation xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:OfficePhone>520-621-3511</irb:OfficePhone><irb:Department_Organization xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:DirectoryTitle xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:AddressLine1>Ofc of Resp Conduct of Rsch</irb:AddressLine1><irb:AddressLine2/><irb:AddressLine3/><irb:City>TUCSON</irb:City><irb:Country>USA</irb:Country><irb:State>AZ</irb:State><irb:PostalCode>85721-0066</irb:PostalCode><irb:CountryCode>USA</irb:CountryCode><irb:FaxNumber/><irb:PagerNumber/><irb:MobilePhoneNumber/></irb:Person><irb:ReviewerTypeDesc>Secondary</irb:ReviewerTypeDesc><irb:ReviewerTypeCode>2</irb:ReviewerTypeCode></irb:ProtocolReviewer><irb:ProtocolReviewer><irb:Person><irb:PersonID>120158325259</irb:PersonID><irb:LastName>Sherman</irb:LastName><irb:Salutation/><irb:Firstname>Scott</irb:Firstname><irb:Fullname>Scott J Sherman</irb:Fullname><irb:Email>ssherman@email.arizona.edu</irb:Email><irb:Degree xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:OfficeLocation xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:OfficePhone>520-626-2319</irb:OfficePhone><irb:Department_Organization xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:DirectoryTitle xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:AddressLine1>Neurology</irb:AddressLine1><irb:AddressLine2>245023</irb:AddressLine2><irb:AddressLine3/><irb:City>TUCSON</irb:City><irb:Country>USA</irb:Country><irb:State>AZ</irb:State><irb:PostalCode>85724-5023</irb:PostalCode><irb:CountryCode>USA</irb:CountryCode><irb:FaxNumber/><irb:PagerNumber/><irb:MobilePhoneNumber/></irb:Person><irb:ReviewerTypeDesc>Primary</irb:ReviewerTypeDesc><irb:ReviewerTypeCode>1</irb:ReviewerTypeCode></irb:ProtocolReviewer><irb:SubmissionChecklistInfo/><irb:ActionType><irb:ActionId>6</irb:ActionId><irb:ActionTypeCode>308</irb:ActionTypeCode><irb:ActionTypeDescription>Record Committee Decision</irb:ActionTypeDescription><irb:ActionDate>2013-12-18-07:00</irb:ActionDate><irb:ActionComments xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/></irb:ActionType></irb:SubmissionDetails><irb:Minutes><irb:ScheduleId>766</irb:ScheduleId><irb:EntryNumber>3</irb:EntryNumber><irb:EntryTypeCode>3</irb:EntryTypeCode><irb:EntryTypeDesc>Protocol</irb:EntryTypeDesc><irb:EntrySortCode>3</irb:EntrySortCode><irb:ProtocolNumber>1312166321</irb:ProtocolNumber><irb:PrivateCommentFlag>false</irb:PrivateCommentFlag><irb:ProtocolContingencyCode>71</irb:ProtocolContingencyCode><irb:MinuteEntry>Criteria for Approval has been met (45 CFR 46.111): The criteria for approval listed in 45 CFR 46.111 have been met (or if previously met, have not changed) in that (1) Risks to subjects are minimized: (i) By using procedures which are consistent with sound research design and which do not unnecessarily expose subjects to risk, and (ii) whenever appropriate, by using procedures already being performed on the subjects for diagnostic or treatment purposes. (2) Risks to subjects are reasonable in relation to anticipated benefits, if any, to subjects, and the importance of the knowledge that may reasonably be expected to result. In evaluating risks and benefits, the IRB should consider only those risks and benefits that may result from the research (as distinguished from risks and benefits of therapies subjects would receive even if not participating in the research). The IRB should not consider possible long-range effects of applying knowledge gained in the research (for example, the possible effects of the research on public policy) as among those research risks that fall within the purview of its responsibility. (3) Selection of subjects is equitable. In making this assessment the IRB should take into account the purposes of the research and the setting in which the research will be conducted and should be particularly cognizant of the special problems of research involving vulnerable populations, such as children, prisoners, pregnant women, mentally disabled persons, or economically or educationally disadvantaged persons. (4) Informed consent will be sought from each prospective subject or the subject's legally authorized representative, in accordance with, and to the extent required by 46.116. (5) Informed consent will be appropriately documented, in accordance with, and to the extent required by 46.117. (6) When appropriate, the research plan makes adequate provision for monitoring the data collected to ensure the safety of subjects. (7) When appropriate, there are adequate provisions to protect the privacy of subjects and to maintain the confidentiality of data. (b) When some or all of the subjects are likely to be vulnerable to coercion or undue influence, such as children, prisoners, pregnant women, mentally disabled persons, or economically or educationally disadvantaged persons, additional safeguards have been included in the study to protect the rights and welfare of these subjects.</irb:MinuteEntry></irb:Minutes></irb:ProtocolSubmission><irb:ProtocolSubmission><irb:ProtocolSummary><irb:ProtocolMasterData><irb:ProtocolNumber>1312167027</irb:ProtocolNumber><irb:SequenceNumber>2</irb:SequenceNumber><irb:ProtocolTypeCode>3</irb:ProtocolTypeCode><irb:ProtocolTypeDesc>Humanitarian Use Device (HUD)</irb:ProtocolTypeDesc><irb:ProtocolStatusCode>200</irb:ProtocolStatusCode><irb:ProtocolStatusDesc>Active - Open to Enrollment</irb:ProtocolStatusDesc><irb:ProtocolTitle>Humanitarian Use of JOSTENT Coronary Stent Graft And JOSTENT Graftmaster [H000001 and H000001/S2]</irb:ProtocolTitle><irb:ApprovalDate>2013-12-17-07:00</irb:ApprovalDate><irb:ExpirationDate>2014-12-16-07:00</irb:ExpirationDate></irb:ProtocolMasterData><irb:Investigator><irb:Person><irb:PersonID>114047960164</irb:PersonID><irb:LastName>Lee</irb:LastName><irb:Salutation/><irb:Firstname>Kwan</irb:Firstname><irb:Fullname>Kwan S Lee</irb:Fullname><irb:Email>kslee@email.arizona.edu</irb:Email><irb:Degree xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:OfficeLocation xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:OfficePhone>520-874-3278</irb:OfficePhone><irb:Department_Organization xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:DirectoryTitle xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:AddressLine1>Medicine</irb:AddressLine1><irb:AddressLine2>245037</irb:AddressLine2><irb:AddressLine3/><irb:City>TUCSON</irb:City><irb:Country>USA</irb:Country><irb:State>AZ</irb:State><irb:PostalCode>85724-5099</irb:PostalCode><irb:CountryCode>USA</irb:CountryCode><irb:FaxNumber/><irb:PagerNumber/><irb:MobilePhoneNumber/></irb:Person><irb:PI_flag>true</irb:PI_flag></irb:Investigator><irb:FundingSource><irb:TypeOfFundingSource>Sponsor (external funding)</irb:TypeOfFundingSource><irb:FundingSourceName>Abbott Laboratories</irb:FundingSourceName></irb:FundingSource></irb:ProtocolSummary><irb:SubmissionDetails><irb:ProtocolNumber>1312167027</irb:ProtocolNumber><irb:SubmissionNumber>3</irb:SubmissionNumber><irb:SubmissionTypeCode>116</irb:SubmissionTypeCode><irb:SubmissionTypeDesc>Resubmission</irb:SubmissionTypeDesc><irb:ProtocolReviewTypeCode>1</irb:ProtocolReviewTypeCode><irb:ProtocolReviewTypeDesc>Full</irb:ProtocolReviewTypeDesc><irb:SubmissionStatusCode>203</irb:SubmissionStatusCode><irb:SubmissionStatusDesc>Approved</irb:SubmissionStatusDesc><irb:SubmissionDate>2013-12-16-07:00</irb:SubmissionDate><irb:YesVote>0</irb:YesVote><irb:NoVote>0</irb:NoVote><irb:AbstainerCount>0</irb:AbstainerCount><irb:VotingComments xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:ProtocolReviewer><irb:Person><irb:PersonID>107627071238</irb:PersonID><irb:LastName>Keegstra</irb:LastName><irb:Salutation/><irb:Firstname>Carroll</irb:Firstname><irb:Fullname>Carroll  Keegstra</irb:Fullname><irb:Email>carrollkeegstra@email.arizona.edu</irb:Email><irb:Degree xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:OfficeLocation xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:OfficePhone>520-621-3513</irb:OfficePhone><irb:Department_Organization xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:DirectoryTitle xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:AddressLine1>VP for Research Office</irb:AddressLine1><irb:AddressLine2/><irb:AddressLine3/><irb:City>TUCSON</irb:City><irb:Country>USA</irb:Country><irb:State>AZ</irb:State><irb:PostalCode>85721-0066</irb:PostalCode><irb:CountryCode>USA</irb:CountryCode><irb:FaxNumber/><irb:PagerNumber/><irb:MobilePhoneNumber/></irb:Person><irb:ReviewerTypeDesc>Secondary</irb:ReviewerTypeDesc><irb:ReviewerTypeCode>2</irb:ReviewerTypeCode></irb:ProtocolReviewer><irb:ProtocolReviewer><irb:Person><irb:PersonID>103117628452</irb:PersonID><irb:LastName>Lichtenthal</irb:LastName><irb:Salutation/><irb:Firstname>Peter</irb:Firstname><irb:Fullname>Peter R Lichtenthal</irb:Fullname><irb:Email>plich@email.arizona.edu</irb:Email><irb:Degree xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:OfficeLocation xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:OfficePhone>520-626-7221</irb:OfficePhone><irb:Department_Organization xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:DirectoryTitle xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:AddressLine1>Anesthesiology</irb:AddressLine1><irb:AddressLine2>245114</irb:AddressLine2><irb:AddressLine3/><irb:City>TUCSON</irb:City><irb:Country>USA</irb:Country><irb:State>AZ</irb:State><irb:PostalCode>85724-5114</irb:PostalCode><irb:CountryCode>USA</irb:CountryCode><irb:FaxNumber/><irb:PagerNumber/><irb:MobilePhoneNumber/></irb:Person><irb:ReviewerTypeDesc>Primary</irb:ReviewerTypeDesc><irb:ReviewerTypeCode>1</irb:ReviewerTypeCode></irb:ProtocolReviewer><irb:SubmissionChecklistInfo/><irb:ActionType><irb:ActionId>7</irb:ActionId><irb:ActionTypeCode>200</irb:ActionTypeCode><irb:ActionTypeDescription>Assigned to Agenda</irb:ActionTypeDescription><irb:ActionDate>2013-12-16-07:00</irb:ActionDate><irb:ActionComments xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/></irb:ActionType></irb:SubmissionDetails><irb:Minutes><irb:ScheduleId>766</irb:ScheduleId><irb:EntryNumber>10</irb:EntryNumber><irb:EntryTypeCode>3</irb:EntryTypeCode><irb:EntryTypeDesc>Protocol</irb:EntryTypeDesc><irb:EntrySortCode>3</irb:EntrySortCode><irb:ProtocolNumber>1312167027</irb:ProtocolNumber><irb:PrivateCommentFlag>false</irb:PrivateCommentFlag><irb:ProtocolContingencyCode>50</irb:ProtocolContingencyCode><irb:MinuteEntry>HUD Eligible for Future Expedited Continuing Review (21 CFR 56.110): Upon reassessment of risk at the IRB Committee meeting, it was determined that expedited continuing review was appropriate as allowed under FDA guidance for continuing review of Humanitarian Use Devices.</irb:MinuteEntry></irb:Minutes></irb:ProtocolSubmission><irb:ProtocolSubmission><irb:ProtocolSummary><irb:ProtocolMasterData><irb:ProtocolNumber>1312166668</irb:ProtocolNumber><irb:SequenceNumber>0</irb:SequenceNumber><irb:ProtocolTypeCode>1</irb:ProtocolTypeCode><irb:ProtocolTypeDesc>Standard</irb:ProtocolTypeDesc><irb:ProtocolStatusCode>200</irb:ProtocolStatusCode><irb:ProtocolStatusDesc>Active - Open to Enrollment</irb:ProtocolStatusDesc><irb:ProtocolTitle>GRADS SARCOIDOSIS</irb:ProtocolTitle><irb:ApprovalDate>2013-12-17-07:00</irb:ApprovalDate><irb:ExpirationDate>2014-12-16-07:00</irb:ExpirationDate></irb:ProtocolMasterData><irb:Investigator><irb:Person><irb:PersonID>116670560447</irb:PersonID><irb:LastName>Garcia</irb:LastName><irb:Salutation/><irb:Firstname>Joe</irb:Firstname><irb:Fullname>Joe GN Garcia</irb:Fullname><irb:Email>skipgarcia@email.arizona.edu</irb:Email><irb:Degree xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:OfficeLocation xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:OfficePhone>520-626-1197</irb:OfficePhone><irb:Department_Organization xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:DirectoryTitle xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:AddressLine1>Senior VP Health Sciences</irb:AddressLine1><irb:AddressLine2>PO Box 210202</irb:AddressLine2><irb:AddressLine3/><irb:City>TUCSON</irb:City><irb:Country>USA</irb:Country><irb:State>AZ</irb:State><irb:PostalCode>85724-5019</irb:PostalCode><irb:CountryCode>USA</irb:CountryCode><irb:FaxNumber/><irb:PagerNumber/><irb:MobilePhoneNumber/></irb:Person><irb:PI_flag>true</irb:PI_flag></irb:Investigator><irb:FundingSource><irb:TypeOfFundingSource>Sponsor (external funding)</irb:TypeOfFundingSource><irb:FundingSourceName>National Heart, Lung, and Blood Institute</irb:FundingSourceName></irb:FundingSource></irb:ProtocolSummary><irb:SubmissionDetails><irb:ProtocolNumber>1312166668</irb:ProtocolNumber><irb:SubmissionNumber>1</irb:SubmissionNumber><irb:SubmissionTypeCode>100</irb:SubmissionTypeCode><irb:SubmissionTypeDesc>Initial Protocol Application for Approval</irb:SubmissionTypeDesc><irb:ProtocolReviewTypeCode>1</irb:ProtocolReviewTypeCode><irb:ProtocolReviewTypeDesc>Full</irb:ProtocolReviewTypeDesc><irb:SubmissionStatusCode>203</irb:SubmissionStatusCode><irb:SubmissionStatusDesc>Approved</irb:SubmissionStatusDesc><irb:SubmissionDate>2013-12-16-07:00</irb:SubmissionDate><irb:YesVote>0</irb:YesVote><irb:NoVote>0</irb:NoVote><irb:AbstainerCount>0</irb:AbstainerCount><irb:VotingComments xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:ProtocolReviewer><irb:Person><irb:PersonID>117950634043</irb:PersonID><irb:LastName>Parthasarathy</irb:LastName><irb:Salutation/><irb:Firstname>Sairam</irb:Firstname><irb:Fullname>Sairam  Parthasarathy</irb:Fullname><irb:Email>spartha1@email.arizona.edu</irb:Email><irb:Degree xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:OfficeLocation xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:OfficePhone>520-626-8309</irb:OfficePhone><irb:Department_Organization xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:DirectoryTitle xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:AddressLine1>Medicine</irb:AddressLine1><irb:AddressLine2>245030</irb:AddressLine2><irb:AddressLine3/><irb:City>TUCSON</irb:City><irb:Country>USA</irb:Country><irb:State>AZ</irb:State><irb:PostalCode>85724-5099</irb:PostalCode><irb:CountryCode>USA</irb:CountryCode><irb:FaxNumber/><irb:PagerNumber/><irb:MobilePhoneNumber/></irb:Person><irb:ReviewerTypeDesc>Primary</irb:ReviewerTypeDesc><irb:ReviewerTypeCode>1</irb:ReviewerTypeCode></irb:ProtocolReviewer><irb:ProtocolReviewer><irb:Person><irb:PersonID>116967231357</irb:PersonID><irb:LastName>Wertheimer</irb:LastName><irb:Salutation/><irb:Firstname>Anne</irb:Firstname><irb:Fullname>Anne M Wertheimer</irb:Fullname><irb:Email>awerth@email.arizona.edu</irb:Email><irb:Degree xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:OfficeLocation xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:OfficePhone>520-626-5850</irb:OfficePhone><irb:Department_Organization xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:DirectoryTitle xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:AddressLine1>Arizona Center on Aging</irb:AddressLine1><irb:AddressLine2>245027</irb:AddressLine2><irb:AddressLine3/><irb:City>TUCSON</irb:City><irb:Country>USA</irb:Country><irb:State>AZ</irb:State><irb:PostalCode>85724-5027</irb:PostalCode><irb:CountryCode>USA</irb:CountryCode><irb:FaxNumber/><irb:PagerNumber/><irb:MobilePhoneNumber/></irb:Person><irb:ReviewerTypeDesc>Secondary</irb:ReviewerTypeDesc><irb:ReviewerTypeCode>2</irb:ReviewerTypeCode></irb:ProtocolReviewer><irb:SubmissionChecklistInfo/><irb:ActionType><irb:ActionId>3</irb:ActionId><irb:ActionTypeCode>200</irb:ActionTypeCode><irb:ActionTypeDescription>Assigned to Agenda</irb:ActionTypeDescription><irb:ActionDate>2013-12-16-07:00</irb:ActionDate><irb:ActionComments xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/></irb:ActionType></irb:SubmissionDetails><irb:Minutes><irb:ScheduleId>766</irb:ScheduleId><irb:EntryNumber>5</irb:EntryNumber><irb:EntryTypeCode>3</irb:EntryTypeCode><irb:EntryTypeDesc>Protocol</irb:EntryTypeDesc><irb:EntrySortCode>3</irb:EntrySortCode><irb:ProtocolNumber>1312166668</irb:ProtocolNumber><irb:PrivateCommentFlag>false</irb:PrivateCommentFlag><irb:ProtocolContingencyCode>71</irb:ProtocolContingencyCode><irb:MinuteEntry>Criteria for Approval has been met (45 CFR 46.111): The criteria for approval listed in 45 CFR 46.111 have been met (or if previously met, have not changed) in that (1) Risks to subjects are minimized: (i) By using procedures which are consistent with sound research design and which do not unnecessarily expose subjects to risk, and (ii) whenever appropriate, by using procedures already being performed on the subjects for diagnostic or treatment purposes. (2) Risks to subjects are reasonable in relation to anticipated benefits, if any, to subjects, and the importance of the knowledge that may reasonably be expected to result. In evaluating risks and benefits, the IRB should consider only those risks and benefits that may result from the research (as distinguished from risks and benefits of therapies subjects would receive even if not participating in the research). The IRB should not consider possible long-range effects of applying knowledge gained in the research (for example, the possible effects of the research on public policy) as among those research risks that fall within the purview of its responsibility. (3) Selection of subjects is equitable. In making this assessment the IRB should take into account the purposes of the research and the setting in which the research will be conducted and should be particularly cognizant of the special problems of research involving vulnerable populations, such as children, prisoners, pregnant women, mentally disabled persons, or economically or educationally disadvantaged persons. (4) Informed consent will be sought from each prospective subject or the subject's legally authorized representative, in accordance with, and to the extent required by 46.116. (5) Informed consent will be appropriately documented, in accordance with, and to the extent required by 46.117. (6) When appropriate, the research plan makes adequate provision for monitoring the data collected to ensure the safety of subjects. (7) When appropriate, there are adequate provisions to protect the privacy of subjects and to maintain the confidentiality of data. (b) When some or all of the subjects are likely to be vulnerable to coercion or undue influence, such as children, prisoners, pregnant women, mentally disabled persons, or economically or educationally disadvantaged persons, additional safeguards have been included in the study to protect the rights and welfare of these subjects.</irb:MinuteEntry></irb:Minutes><irb:Minutes><irb:ScheduleId>766</irb:ScheduleId><irb:EntryNumber>6</irb:EntryNumber><irb:EntryTypeCode>3</irb:EntryTypeCode><irb:EntryTypeDesc>Protocol</irb:EntryTypeDesc><irb:EntrySortCode>3</irb:EntrySortCode><irb:ProtocolNumber>1312166668</irb:ProtocolNumber><irb:PrivateCommentFlag>false</irb:PrivateCommentFlag><irb:ProtocolContingencyCode>124</irb:ProtocolContingencyCode><irb:MinuteEntry>Partial Waiver of PHI Authorization (45 CFR 164.512(i)(2)(ii)): As documented in the file, the use or disclosure of protected health information involves no more than minimal risk to the individuals ; the research could not practicably be conducted without the alteration or waiver ;the research could not practicably be conducted without access to and use of the protected health information ; there is an adequate plan to protect the identifiers from improper use and disclosure ; there is an adequate plan to destroy the identifiers at the earliest opportunity consistent with conduct of the research, unless there is a health or research justification for retaining the identifiers, or such retention is otherwise required by law ; and there are adequate written assurances that the protected health information will not be reused or disclosed to any other person or entity, except as required by law, for authorized oversight of the research project, or for other research for which the use or disclosure of protected health information would be permitted by this subpart.</irb:MinuteEntry></irb:Minutes></irb:ProtocolSubmission><irb:ProtocolSubmission><irb:ProtocolSummary><irb:ProtocolMasterData><irb:ProtocolNumber>1312167222</irb:ProtocolNumber><irb:SequenceNumber>0</irb:SequenceNumber><irb:ProtocolTypeCode>1</irb:ProtocolTypeCode><irb:ProtocolTypeDesc>Standard</irb:ProtocolTypeDesc><irb:ProtocolStatusCode>200</irb:ProtocolStatusCode><irb:ProtocolStatusDesc>Active - Open to Enrollment</irb:ProtocolStatusDesc><irb:ProtocolTitle>Genomic Prediction of Chronic Pulmonary Inflammation in HIV Infection</irb:ProtocolTitle><irb:ApprovalDate>2013-12-17-07:00</irb:ApprovalDate><irb:ExpirationDate>2014-12-16-07:00</irb:ExpirationDate></irb:ProtocolMasterData><irb:Investigator><irb:Person><irb:PersonID>119932947625</irb:PersonID><irb:LastName>Knox</irb:LastName><irb:Salutation/><irb:Firstname>Kenneth</irb:Firstname><irb:Fullname>Kenneth S Knox</irb:Fullname><irb:Email>knox@email.arizona.edu</irb:Email><irb:Degree xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:OfficeLocation xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:OfficePhone>520-626-6114</irb:OfficePhone><irb:Department_Organization xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:DirectoryTitle xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:AddressLine1>Medicine</irb:AddressLine1><irb:AddressLine2>245030</irb:AddressLine2><irb:AddressLine3/><irb:City>TUCSON</irb:City><irb:Country>USA</irb:Country><irb:State>AZ</irb:State><irb:PostalCode>85724-5099</irb:PostalCode><irb:CountryCode>USA</irb:CountryCode><irb:FaxNumber/><irb:PagerNumber/><irb:MobilePhoneNumber/></irb:Person><irb:PI_flag>true</irb:PI_flag></irb:Investigator><irb:FundingSource><irb:TypeOfFundingSource>Sponsor (external funding)</irb:TypeOfFundingSource><irb:FundingSourceName>National Institutes of Health</irb:FundingSourceName></irb:FundingSource></irb:ProtocolSummary><irb:SubmissionDetails><irb:ProtocolNumber>1312167222</irb:ProtocolNumber><irb:SubmissionNumber>1</irb:SubmissionNumber><irb:SubmissionTypeCode>100</irb:SubmissionTypeCode><irb:SubmissionTypeDesc>Initial Protocol Application for Approval</irb:SubmissionTypeDesc><irb:ProtocolReviewTypeCode>1</irb:ProtocolReviewTypeCode><irb:ProtocolReviewTypeDesc>Full</irb:ProtocolReviewTypeDesc><irb:SubmissionStatusCode>203</irb:SubmissionStatusCode><irb:SubmissionStatusDesc>Approved</irb:SubmissionStatusDesc><irb:SubmissionDate>2013-12-16-07:00</irb:SubmissionDate><irb:YesVote>0</irb:YesVote><irb:NoVote>0</irb:NoVote><irb:AbstainerCount>0</irb:AbstainerCount><irb:VotingComments xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:ProtocolReviewer><irb:Person><irb:PersonID>119454107227</irb:PersonID><irb:LastName>Burkhead</irb:LastName><irb:Salutation/><irb:Firstname>Tamara</irb:Firstname><irb:Fullname>Tamara J Burkhead</irb:Fullname><irb:Email>tburkhead@azcc.arizona.edu</irb:Email><irb:Degree xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:OfficeLocation xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:OfficePhone>520-626-0213</irb:OfficePhone><irb:Department_Organization xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:DirectoryTitle xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:AddressLine1>Cancer Center Division</irb:AddressLine1><irb:AddressLine2>245024</irb:AddressLine2><irb:AddressLine3/><irb:City>TUCSON</irb:City><irb:Country>USA</irb:Country><irb:State>AZ</irb:State><irb:PostalCode>85724-5024</irb:PostalCode><irb:CountryCode>USA</irb:CountryCode><irb:FaxNumber/><irb:PagerNumber/><irb:MobilePhoneNumber/></irb:Person><irb:ReviewerTypeDesc>Secondary</irb:ReviewerTypeDesc><irb:ReviewerTypeCode>2</irb:ReviewerTypeCode></irb:ProtocolReviewer><irb:ProtocolReviewer><irb:Person><irb:PersonID>115605455407</irb:PersonID><irb:LastName>Goodwin</irb:LastName><irb:Salutation/><irb:Firstname>James</irb:Firstname><irb:Fullname>James L Goodwin</irb:Fullname><irb:Email>jamieg@arc.arizona.edu</irb:Email><irb:Degree xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:OfficeLocation xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:OfficePhone>520-626-5001</irb:OfficePhone><irb:Department_Organization xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:DirectoryTitle xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:AddressLine1>Arizona Respiratory Center</irb:AddressLine1><irb:AddressLine2>245030</irb:AddressLine2><irb:AddressLine3/><irb:City>TUCSON</irb:City><irb:Country>USA</irb:Country><irb:State>AZ</irb:State><irb:PostalCode>85724-5030</irb:PostalCode><irb:CountryCode>USA</irb:CountryCode><irb:FaxNumber/><irb:PagerNumber/><irb:MobilePhoneNumber/></irb:Person><irb:ReviewerTypeDesc>Primary</irb:ReviewerTypeDesc><irb:ReviewerTypeCode>1</irb:ReviewerTypeCode></irb:ProtocolReviewer><irb:SubmissionChecklistInfo/><irb:ActionType><irb:ActionId>3</irb:ActionId><irb:ActionTypeCode>200</irb:ActionTypeCode><irb:ActionTypeDescription>Assigned to Agenda</irb:ActionTypeDescription><irb:ActionDate>2013-12-16-07:00</irb:ActionDate><irb:ActionComments xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/></irb:ActionType></irb:SubmissionDetails><irb:Minutes><irb:ScheduleId>766</irb:ScheduleId><irb:EntryNumber>4</irb:EntryNumber><irb:EntryTypeCode>3</irb:EntryTypeCode><irb:EntryTypeDesc>Protocol</irb:EntryTypeDesc><irb:EntrySortCode>3</irb:EntrySortCode><irb:ProtocolNumber>1312167222</irb:ProtocolNumber><irb:PrivateCommentFlag>false</irb:PrivateCommentFlag><irb:ProtocolContingencyCode>71</irb:ProtocolContingencyCode><irb:MinuteEntry>Criteria for Approval has been met (45 CFR 46.111): The criteria for approval listed in 45 CFR 46.111 have been met (or if previously met, have not changed) in that (1) Risks to subjects are minimized: (i) By using procedures which are consistent with sound research design and which do not unnecessarily expose subjects to risk, and (ii) whenever appropriate, by using procedures already being performed on the subjects for diagnostic or treatment purposes. (2) Risks to subjects are reasonable in relation to anticipated benefits, if any, to subjects, and the importance of the knowledge that may reasonably be expected to result. In evaluating risks and benefits, the IRB should consider only those risks and benefits that may result from the research (as distinguished from risks and benefits of therapies subjects would receive even if not participating in the research). The IRB should not consider possible long-range effects of applying knowledge gained in the research (for example, the possible effects of the research on public policy) as among those research risks that fall within the purview of its responsibility. (3) Selection of subjects is equitable. In making this assessment the IRB should take into account the purposes of the research and the setting in which the research will be conducted and should be particularly cognizant of the special problems of research involving vulnerable populations, such as children, prisoners, pregnant women, mentally disabled persons, or economically or educationally disadvantaged persons. (4) Informed consent will be sought from each prospective subject or the subject's legally authorized representative, in accordance with, and to the extent required by 46.116. (5) Informed consent will be appropriately documented, in accordance with, and to the extent required by 46.117. (6) When appropriate, the research plan makes adequate provision for monitoring the data collected to ensure the safety of subjects. (7) When appropriate, there are adequate provisions to protect the privacy of subjects and to maintain the confidentiality of data. (b) When some or all of the subjects are likely to be vulnerable to coercion or undue influence, such as children, prisoners, pregnant women, mentally disabled persons, or economically or educationally disadvantaged persons, additional safeguards have been included in the study to protect the rights and welfare of these subjects.</irb:MinuteEntry></irb:Minutes></irb:ProtocolSubmission><irb:ProtocolSubmission><irb:ProtocolSummary><irb:ProtocolMasterData><irb:ProtocolNumber>1312167559</irb:ProtocolNumber><irb:SequenceNumber>0</irb:SequenceNumber><irb:ProtocolTypeCode>1</irb:ProtocolTypeCode><irb:ProtocolTypeDesc>Standard</irb:ProtocolTypeDesc><irb:ProtocolStatusCode>200</irb:ProtocolStatusCode><irb:ProtocolStatusDesc>Active - Open to Enrollment</irb:ProtocolStatusDesc><irb:ProtocolTitle>A Phase II Study of Vemurafenib Combined with Acitretin in Patients with Advanced Melanoma</irb:ProtocolTitle><irb:ProtocolDescription>Drug- Vemurafenib
Drug- Acitretin

IND Exempt for Both Drugs</irb:ProtocolDescription><irb:ApprovalDate>2013-12-17-07:00</irb:ApprovalDate><irb:ExpirationDate>2014-12-16-07:00</irb:ExpirationDate></irb:ProtocolMasterData><irb:Investigator><irb:Person><irb:PersonID>115700578463</irb:PersonID><irb:LastName>Cranmer</irb:LastName><irb:Salutation/><irb:Firstname>Lee</irb:Firstname><irb:Fullname>Lee D Cranmer</irb:Fullname><irb:Email>lcranmer@azcc.arizona.edu</irb:Email><irb:Degree xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:OfficeLocation xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:OfficePhone>520-626-0501</irb:OfficePhone><irb:Department_Organization xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:DirectoryTitle xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:AddressLine1>Cancer Center Division</irb:AddressLine1><irb:AddressLine2>245024</irb:AddressLine2><irb:AddressLine3/><irb:City>TUCSON</irb:City><irb:Country>USA</irb:Country><irb:State>AZ</irb:State><irb:PostalCode>85724-5024</irb:PostalCode><irb:CountryCode>USA</irb:CountryCode><irb:FaxNumber/><irb:PagerNumber/><irb:MobilePhoneNumber/></irb:Person><irb:PI_flag>true</irb:PI_flag></irb:Investigator></irb:ProtocolSummary><irb:SubmissionDetails><irb:ProtocolNumber>1312167559</irb:ProtocolNumber><irb:SubmissionNumber>1</irb:SubmissionNumber><irb:SubmissionTypeCode>100</irb:SubmissionTypeCode><irb:SubmissionTypeDesc>Initial Protocol Application for Approval</irb:SubmissionTypeDesc><irb:ProtocolReviewTypeCode>1</irb:ProtocolReviewTypeCode><irb:ProtocolReviewTypeDesc>Full</irb:ProtocolReviewTypeDesc><irb:SubmissionStatusCode>203</irb:SubmissionStatusCode><irb:SubmissionStatusDesc>Approved</irb:SubmissionStatusDesc><irb:SubmissionDate>2013-12-16-07:00</irb:SubmissionDate><irb:YesVote>0</irb:YesVote><irb:NoVote>0</irb:NoVote><irb:AbstainerCount>0</irb:AbstainerCount><irb:VotingComments xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:ProtocolReviewer><irb:Person><irb:PersonID>115545259718</irb:PersonID><irb:LastName>Moore</irb:LastName><irb:Salutation/><irb:Firstname>Ida</irb:Firstname><irb:Fullname>Ida M Moore</irb:Fullname><irb:Email>imoore@email.arizona.edu</irb:Email><irb:Degree xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:OfficeLocation xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:OfficePhone>520-626-6205</irb:OfficePhone><irb:Department_Organization xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:DirectoryTitle xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:AddressLine1>College of Nursing</irb:AddressLine1><irb:AddressLine2>PO Box 210203</irb:AddressLine2><irb:AddressLine3/><irb:City>Tucson</irb:City><irb:Country>USA</irb:Country><irb:State>AZ</irb:State><irb:PostalCode>85721</irb:PostalCode><irb:CountryCode>USA</irb:CountryCode><irb:FaxNumber/><irb:PagerNumber/><irb:MobilePhoneNumber/></irb:Person><irb:ReviewerTypeDesc>Secondary</irb:ReviewerTypeDesc><irb:ReviewerTypeCode>2</irb:ReviewerTypeCode></irb:ProtocolReviewer><irb:ProtocolReviewer><irb:Person><irb:PersonID>116666954717</irb:PersonID><irb:LastName>Wittman</irb:LastName><irb:Salutation/><irb:Firstname>Brenda</irb:Firstname><irb:Fullname>Brenda J Wittman</irb:Fullname><irb:Email>wittman@peds.arizona.edu</irb:Email><irb:Degree xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:OfficeLocation xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:OfficePhone>520-626-4851</irb:OfficePhone><irb:Department_Organization xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:DirectoryTitle xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:AddressLine1>Pediatrics</irb:AddressLine1><irb:AddressLine2>245073</irb:AddressLine2><irb:AddressLine3/><irb:City>TUCSON</irb:City><irb:Country>USA</irb:Country><irb:State>AZ</irb:State><irb:PostalCode>85724-5073</irb:PostalCode><irb:CountryCode>USA</irb:CountryCode><irb:FaxNumber/><irb:PagerNumber/><irb:MobilePhoneNumber/></irb:Person><irb:ReviewerTypeDesc>Primary</irb:ReviewerTypeDesc><irb:ReviewerTypeCode>1</irb:ReviewerTypeCode></irb:ProtocolReviewer><irb:SubmissionChecklistInfo/><irb:ActionType><irb:ActionId>3</irb:ActionId><irb:ActionTypeCode>200</irb:ActionTypeCode><irb:ActionTypeDescription>Assigned to Agenda</irb:ActionTypeDescription><irb:ActionDate>2013-12-16-07:00</irb:ActionDate><irb:ActionComments xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/></irb:ActionType></irb:SubmissionDetails><irb:Minutes><irb:ScheduleId>766</irb:ScheduleId><irb:EntryNumber>2</irb:EntryNumber><irb:EntryTypeCode>3</irb:EntryTypeCode><irb:EntryTypeDesc>Protocol</irb:EntryTypeDesc><irb:EntrySortCode>3</irb:EntrySortCode><irb:ProtocolNumber>1312167559</irb:ProtocolNumber><irb:PrivateCommentFlag>false</irb:PrivateCommentFlag><irb:ProtocolContingencyCode>71</irb:ProtocolContingencyCode><irb:MinuteEntry>Criteria for Approval has been met (45 CFR 46.111): The criteria for approval listed in 45 CFR 46.111 have been met (or if previously met, have not changed) in that (1) Risks to subjects are minimized: (i) By using procedures which are consistent with sound research design and which do not unnecessarily expose subjects to risk, and (ii) whenever appropriate, by using procedures already being performed on the subjects for diagnostic or treatment purposes. (2) Risks to subjects are reasonable in relation to anticipated benefits, if any, to subjects, and the importance of the knowledge that may reasonably be expected to result. In evaluating risks and benefits, the IRB should consider only those risks and benefits that may result from the research (as distinguished from risks and benefits of therapies subjects would receive even if not participating in the research). The IRB should not consider possible long-range effects of applying knowledge gained in the research (for example, the possible effects of the research on public policy) as among those research risks that fall within the purview of its responsibility. (3) Selection of subjects is equitable. In making this assessment the IRB should take into account the purposes of the research and the setting in which the research will be conducted and should be particularly cognizant of the special problems of research involving vulnerable populations, such as children, prisoners, pregnant women, mentally disabled persons, or economically or educationally disadvantaged persons. (4) Informed consent will be sought from each prospective subject or the subject's legally authorized representative, in accordance with, and to the extent required by 46.116. (5) Informed consent will be appropriately documented, in accordance with, and to the extent required by 46.117. (6) When appropriate, the research plan makes adequate provision for monitoring the data collected to ensure the safety of subjects. (7) When appropriate, there are adequate provisions to protect the privacy of subjects and to maintain the confidentiality of data. (b) When some or all of the subjects are likely to be vulnerable to coercion or undue influence, such as children, prisoners, pregnant women, mentally disabled persons, or economically or educationally disadvantaged persons, additional safeguards have been included in the study to protect the rights and welfare of these subjects.</irb:MinuteEntry></irb:Minutes></irb:ProtocolSubmission><irb:ProtocolSubmission><irb:ProtocolSummary><irb:ProtocolMasterData><irb:ProtocolNumber>1312167790</irb:ProtocolNumber><irb:SequenceNumber>1</irb:SequenceNumber><irb:ProtocolTypeCode>1</irb:ProtocolTypeCode><irb:ProtocolTypeDesc>Standard</irb:ProtocolTypeDesc><irb:ProtocolStatusCode>200</irb:ProtocolStatusCode><irb:ProtocolStatusDesc>Active - Open to Enrollment</irb:ProtocolStatusDesc><irb:ProtocolTitle>Acupuncture versus medication: A comparison of treatments for overactive bladder in an elderly female population</irb:ProtocolTitle><irb:ProtocolDescription>Drug-Oxybutynin</irb:ProtocolDescription><irb:ApprovalDate>2013-12-19-07:00</irb:ApprovalDate><irb:ExpirationDate>2014-12-18-07:00</irb:ExpirationDate></irb:ProtocolMasterData><irb:Investigator><irb:Person><irb:PersonID>105280839669</irb:PersonID><irb:LastName>Addis</irb:LastName><irb:Salutation/><irb:Firstname>Ilana</irb:Firstname><irb:Fullname>Ilana B Addis</irb:Fullname><irb:Email>iaddis@email.arizona.edu</irb:Email><irb:Degree xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:OfficeLocation xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:OfficePhone>520-626-6591</irb:OfficePhone><irb:Department_Organization xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:DirectoryTitle xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:AddressLine1>Obstetrics and Gynecology</irb:AddressLine1><irb:AddressLine2>245078</irb:AddressLine2><irb:AddressLine3/><irb:City>TUCSON</irb:City><irb:Country>USA</irb:Country><irb:State>AZ</irb:State><irb:PostalCode>85724-5078</irb:PostalCode><irb:CountryCode>USA</irb:CountryCode><irb:FaxNumber/><irb:PagerNumber/><irb:MobilePhoneNumber/></irb:Person><irb:PI_flag>true</irb:PI_flag></irb:Investigator><irb:FundingSource><irb:TypeOfFundingSource>Sponsor (external funding)</irb:TypeOfFundingSource><irb:FundingSourceName>National Institute on Aging</irb:FundingSourceName></irb:FundingSource></irb:ProtocolSummary><irb:SubmissionDetails><irb:ProtocolNumber>1312167790</irb:ProtocolNumber><irb:SubmissionNumber>1</irb:SubmissionNumber><irb:SubmissionTypeCode>100</irb:SubmissionTypeCode><irb:SubmissionTypeDesc>Initial Protocol Application for Approval</irb:SubmissionTypeDesc><irb:ProtocolReviewTypeCode>1</irb:ProtocolReviewTypeCode><irb:ProtocolReviewTypeDesc>Full</irb:ProtocolReviewTypeDesc><irb:SubmissionStatusCode>202</irb:SubmissionStatusCode><irb:SubmissionStatusDesc>Specific Minor Revisions Requested</irb:SubmissionStatusDesc><irb:SubmissionDate>2013-12-16-07:00</irb:SubmissionDate><irb:YesVote>0</irb:YesVote><irb:NoVote>0</irb:NoVote><irb:AbstainerCount>0</irb:AbstainerCount><irb:VotingComments xsi:nil="true" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"/><irb:SubmissionChecklistInfo/><irb:ActionType><irb:ActionId>2</irb:ActionId><irb:ActionTypeCode>101</irb:ActionTypeCode><irb:ActionTypeDescription>Submitted to IRB</irb:ActionTypeDescription><irb:ActionDate>2013-12-16-07:00</irb:ActionDate><irb:ActionComments>Submitted to IRB</irb:ActionComments></irb:ActionType></irb:SubmissionDetails><irb:Minutes><irb:ScheduleId>766</irb:ScheduleId><irb:EntryNumber>0</irb:EntryNumber><irb:EntryTypeCode>3</irb:EntryTypeCode><irb:EntryTypeDesc>Protocol</irb:EntryTypeDesc><irb:EntrySortCode>3</irb:EntrySortCode><irb:ProtocolNumber>1312167790</irb:ProtocolNumber><irb:PrivateCommentFlag>false</irb:PrivateCommentFlag><irb:ProtocolContingencyCode>48</irb:ProtocolContingencyCode><irb:MinuteEntry>Please respond to the IRB Committee no later than Friday, December 6th.  If materials are not received by this date, the project will be withdrawn.  The PI must include the text of each comment followed by the response.  The version date of all revised documents must be updated to match the date of the Modifications and all revisions tracked or highlighted in gray.</irb:MinuteEntry></irb:Minutes></irb:ProtocolSubmission><irb:Attendents><irb:AttendentName>Ilana B Addis</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:Attendents><irb:AttendentName>Srikar R Adhikari</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:Attendents><irb:AttendentName>Shirin D Antia</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:Attendents><irb:AttendentName>Diana B Archangeli</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:Attendents><irb:AttendentName>Linda  Baribeau</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:Attendents><irb:AttendentName>Bruce J Barnhart</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:Attendents><irb:AttendentName>Yira  Bermudez</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:Attendents><irb:AttendentName>Manish  Bharara</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:Attendents><irb:AttendentName>Joseph A Bonito</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:Attendents><irb:AttendentName>Leslie V Boyer</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:Attendents><irb:AttendentName>Nicholas Jk Breitborde</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:Attendents><irb:AttendentName>Michael M Brewer</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:Attendents><irb:AttendentName>Eric  Brody</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:Attendents><irb:AttendentName>Merrie L Brucks</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:Attendents><irb:AttendentName>Tamara J Burkhead</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:Attendents><irb:AttendentName>James Michael Camamo</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:Attendents><irb:AttendentName>Noel A Card</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:Attendents><irb:AttendentName>Alexander G Chiu</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:Attendents><irb:AttendentName>Jenny W Chong</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:Attendents><irb:AttendentName>Chih-Chin  Chou</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:Attendents><irb:AttendentName>Hsiao-Hui  Chow</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:Attendents><irb:AttendentName>Terence  Connolly</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:Attendents><irb:AttendentName>Angela  Davis</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:Attendents><irb:AttendentName>Janice A Degan</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:Attendents><irb:AttendentName>Regina J Deil-Amen</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:Attendents><irb:AttendentName>Kurt R Denninghoff</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:Attendents><irb:AttendentName>Miguel A Diaz</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:Attendents><irb:AttendentName>Edward I Donnerstein</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:Attendents><irb:AttendentName>Martin  Dufwenberg</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:Attendents><irb:AttendentName>Peggy Reed Dunlap</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:Attendents><irb:AttendentName>Mohamed I Elyan</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:Attendents><irb:AttendentName>Thomas J Ferguson</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:Attendents><irb:AttendentName>Celestino  Fernandez</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:Attendents><irb:AttendentName>Kenneth I Forster</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:Attendents><irb:AttendentName>CEDAR L FOWLER</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:Attendents><irb:AttendentName>Mary Jo Fox</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:Attendents><irb:AttendentName>Randall S Friese</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:Attendents><irb:AttendentName>William Leo Fritz</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:Attendents><irb:AttendentName>Francine C Gachupin</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:Attendents><irb:AttendentName>Carlos A Galvani</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:Attendents><irb:AttendentName>Linda L Garland</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:Attendents><irb:AttendentName>Lynn B Gerald</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:Attendents><irb:AttendentName>Theodore J Glattke</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:Attendents><irb:AttendentName>Scott B Going</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:Attendents><irb:AttendentName>James L Goodwin</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:Attendents><irb:AttendentName>David T Harris</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:Attendents><irb:AttendentName>Jules E Harris</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:Attendents><irb:AttendentName>Robin B Harris</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:Attendents><irb:AttendentName>Richard N Herrier</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:Attendents><irb:AttendentName>Meghan G Hill</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:Attendents><irb:AttendentName>Joanne M Jeter</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:Attendents><irb:AttendentName>Elaine G Jones</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:Attendents><irb:AttendentName>Marie A Jones</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:Attendents><irb:AttendentName>Carroll  Keegstra</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:Attendents><irb:AttendentName>Zain I Khalpey</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:Attendents><irb:AttendentName>Ethan Erik Larson</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:Attendents><irb:AttendentName>Debora  Levine-Donnerstein</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:Attendents><irb:AttendentName>Peter R Lichtenthal</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:Attendents><irb:AttendentName>Eileen M Luna-Firebaugh</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:Attendents><irb:AttendentName>Carol J Maker</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:Attendents><irb:AttendentName>Martin  Malkin</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:Attendents><irb:AttendentName>Joanne M Mallie</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:Attendents><irb:AttendentName>Chad S Marchand</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:Attendents><irb:AttendentName>Robert A Marlow</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:Attendents><irb:AttendentName>Mariette T Marsh</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:Attendents><irb:AttendentName>Jo Ann Matty</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:Attendents><irb:AttendentName>Cecile M Mckee</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:Attendents><irb:AttendentName>Naja E Mckenzie</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:Attendents><irb:AttendentName>Mary Lou Metzger</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:Attendents><irb:AttendentName>Jeffrey F Milem</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:Attendents><irb:AttendentName>Joseph L Mills</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:Attendents><irb:AttendentName>Osmara Y Molina de Rodriguez</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:Attendents><irb:AttendentName>Ida M Moore</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:Attendents><irb:AttendentName>Janet Leslie Nichols</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:Attendents><irb:AttendentName>David E Nix</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:Attendents><irb:AttendentName>Ronald L Oaxaca</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:Attendents><irb:AttendentName>Terence S Okeeffe</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:Attendents><irb:AttendentName>Nancy J Parezo</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:Attendents><irb:AttendentName>Nicole T Pargas</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:Attendents><irb:AttendentName>Thomas K Park</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:Attendents><irb:AttendentName>Sairam  Parthasarathy</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:Attendents><irb:AttendentName>Jitesh A Patel</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:Attendents><irb:AttendentName>Chestalene  Pintozzi</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:Attendents><irb:AttendentName>Christine C Pletkova</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:Attendents><irb:AttendentName>Kelly A Reynolds</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:Attendents><irb:AttendentName>Richard S Rhoads</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:Attendents><irb:AttendentName>Cindy J Rishel</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:Attendents><irb:AttendentName>Ian F Robey</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:Attendents><irb:AttendentName>Hugo A Rocha</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:Attendents><irb:AttendentName>Michael J Rohrbaugh</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:Attendents><irb:AttendentName>Gilbert M Salazar</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:Attendents><irb:AttendentName>Arthur B Sanders</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:Attendents><irb:AttendentName>Charles A Schable</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:Attendents><irb:AttendentName>Kai O Schoenhage</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:Attendents><irb:AttendentName>Joan Rankin Shapiro</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:Attendents><irb:AttendentName>Scott J Sherman</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:Attendents><irb:AttendentName>Farshad  Shirazi</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:Attendents><irb:AttendentName>Anne M Stewart</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:Attendents><irb:AttendentName>Jess L Thompson</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:Attendents><irb:AttendentName>Cynthia A Thomson</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:Attendents><irb:AttendentName>Allison L Titcomb</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:Attendents><irb:AttendentName>GAYLE  TRAVER</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:Attendents><irb:AttendentName>Suzanna C Trejo-Robinson</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:Attendents><irb:AttendentName>Michael H Trujillo</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:Attendents><irb:AttendentName>Christian O Twiss</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:Attendents><irb:AttendentName>Adam P Ussishkin</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:Attendents><irb:AttendentName>Angela C Valencia</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:Attendents><irb:AttendentName>Rebecca K Viscusi</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:Attendents><irb:AttendentName>Natasha  Warner</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:Attendents><irb:AttendentName>Anne M Wertheimer</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:Attendents><irb:AttendentName>Brenda J Wittman</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:Attendents><irb:AttendentName>Leisy T Wyman</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:Attendents><irb:AttendentName>Rose M Ylimaki</irb:AttendentName><irb:GuestFlag>false</irb:GuestFlag><irb:AlternateFlag>false</irb:AlternateFlag><irb:PresentFlag>false</irb:PresentFlag></irb:Attendents><irb:NextSchedule><irb:ScheduleMasterData/></irb:NextSchedule><irb:PreviousSchedule><irb:ScheduleMasterData/></irb:PreviousSchedule></irb:Schedule>